Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elias A. T. Koch"'
Autor:
Elias A. T. Koch, Anne Petzold, Edgar Dippel, Michael Erdmann, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Sebastian Haferkamp, Katharina C. Kähler, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Beatrice Schell, Patrick Terheyden, Kai-Martin Thoms, Selma Ugurel, Jens Ulrich, Jochen Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus V. Heppt
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionDespite recent advancements in the treatment of metastatic uveal melanoma (UM), the availability of further treatment options remains limited and the prognosis continues to be poor in many cases. In addition to tebentafusp, immune checkpo
Externí odkaz:
https://doaj.org/article/e37aacd9f05d43b681af7a4bbdfeb024
Autor:
Kilian Müller, Carola Berking, Caroline Voskens, Markus V. Heppt, Lucie Heinzerling, Elias A. T. Koch, Rafaela Kramer, Susanne Merkel, Beatrice Schuler-Thurner, Vera Schellerer, Theresa Steeb, Anja Wessely, Michael Erdmann
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundIn melanoma, in-transit metastases characteristically occur at the lower extremity along lymphatic vessels.ObjectivesThe objective of this study was to evaluate conventional or three-dimensional photography as a tool to analyze in-transit m
Externí odkaz:
https://doaj.org/article/d4951afd09644ff1ba35f5034e0a5c71
Autor:
Anja Wessely, Theresa Steeb, Franz Heppt, Annkathrin Hornung, Matthias D. Kaufmann, Elias A. T. Koch, Frédéric Toussaint, Michael Erdmann, Carola Berking, Markus V. Heppt
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 950-960 (2021)
Actinic keratoses (AK) are common lesions of the skin that can be effectively treated with several lesion- and field-directed treatments. Clinical practice guidelines assist physicians in choosing the appropriate treatment options for their patients.
Externí odkaz:
https://doaj.org/article/798762f9f7b94e87a79e5706835eb58d
Autor:
Elias A. T. Koch, Niels Schaft, Mirko Kummer, Carola Berking, Gerold Schuler, Kenichiro Hasumi, Jan Dörrie, Beatrice Schuler-Thurner
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Uveal melanoma (UM) is an orphan disease with a mortality of 80% within one year upon the development of metastatic disease. UM does hardly respond to chemotherapy and kinase inhibitors and is largely resistant to checkpoint inhibition. Hence, furthe
Externí odkaz:
https://doaj.org/article/6472911da671458fa687e220434108be
Autor:
Heppt, Elias A. T. Koch, Theresa Steeb, Sophia Bender-Säbelkampf, Dorothee Busch, Janina Feustel, Matthias D. Kaufmann, Andreas Maronna, Christine Meder, Moritz Ronicke, Frédéric Toussaint, Hedwig Wellein, Carola Berking, Markus V.
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 11; Pages: 3813
Background: Many treatments for actinic keratosis (AK) have been proven efficient in clinical trials. However, patients with AK may still experience unsatisfactory therapeutic outcomes in clinical practice. Objectives: To investigate patient adherenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::a4f21cdf5ac6f2d0231e894be7094fe0
Publikováno v:
Expert Opinion on Drug Safety. 20:801-814
Introduction: Actinic keratosis (AK) are proliferations of atypical keratinocytes that may eventually progress to cutaneous squamous cell carcinoma. Therefore, AK requires consequent and early treatment. Areas covered: A variety of effective approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cddcdbd390ecb05ee60f2244868d7a
https://doi.org/10.1080/14740338.2021.1915280
https://doi.org/10.1080/14740338.2021.1915280
Autor:
Elias A. T. Koch, Michael Erdmann, Carola Berking, Franklin Kiesewetter, Rafaela Kramer, Stefan Schliep, Markus V. Heppt
Publikováno v:
International Journal of Molecular Sciences. 24:6388
PRAME (PReferentially expressed Antigen in MElanoma) is a cancer testis antigen that is frequently expressed in melanoma compared to benign melanocytic proliferations and nevi. However, the interpretation of the intensity and distribution of PRAME im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e89b503e6688344d238d18896203a8d7
https://doi.org/10.3390/ijms24076388
https://doi.org/10.3390/ijms24076388
Autor:
Elias A T, Koch, Anne, Petzold, Anja, Wessely, Edgar, Dippel, Anja, Gesierich, Ralf, Gutzmer, Jessica C, Hassel, Sebastian, Haferkamp, Bettina, Hohberger, Katharina C, Kähler, Harald, Knorr, Nicole, Kreuzberg, Ulrike, Leiter, Carmen, Loquai, Friedegund, Meier, Markus, Meissner, Peter, Mohr, Claudia, Pföhler, Farnaz, Rahimi, Dirk, Schadendorf, Beatrice, Schell, Max, Schlaak, Patrick, Terheyden, Kai-Martin, Thoms, Beatrice, Schuler-Thurner, Selma, Ugurel, Jens, Ulrich, Jochen, Utikal, Michael, Weichenthal, Fabian, Ziller, Carola, Berking, Markus V, Heppt, On Behalf Of The German Dermatologic Cooperative Oncology Group DeCOG Committee Ocular Melanoma
Publikováno v:
Cancers
Volume 13
Issue 13
Cancers, Vol 13, Iss 3359, p 3359 (2021)
Volume 13
Issue 13
Cancers, Vol 13, Iss 3359, p 3359 (2021)
Background: Since there is no standardized and effective treatment for advanced uveal melanoma (UM), the prognosis is dismal once metastases develop. Due to the availability of immune checkpoint blockade (ICB) in the real-world setting, the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fc6ce5932093294003a69f8c7ea14054
Publikováno v:
Irish Journal of Medical Science
Irish Journal of Medical Science (1971-)
Irish Journal of Medical Science (1971-)
SARS-CoV-2, causing the lethal disease COVid-19, is a public health emergency in the 2020 global pandemic. The outbreak and fast spreading of SARS-CoV-2 have a high morbidity and mortality specifically in elder patients with chronic diseases such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0cbd0ff688f1535d0e3465b9cfbc74
https://pubmed.ncbi.nlm.nih.gov/33409846
https://pubmed.ncbi.nlm.nih.gov/33409846
Autor:
Yvonne K Schulz, Michael Erdmann, Lucie Heinzerling, Florian T Nickel, Elias A T Koch, Carola Berking
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 44(3)
Checkpoint inhibitors (CPI), such as anti-programmed death-1 and anti-cytotoxic T-lymphocyte antigen-4antibodies cause serious, rarely fatal immune-related adverse events (irAE) potentially in all organ systems. Neurological immune-related adverse ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50317b079c37118c09f15d6a7084c39a
https://pubmed.ncbi.nlm.nih.gov/33369994
https://pubmed.ncbi.nlm.nih.gov/33369994